Watson Pharmaceuticals, Inc. (WPI) Tops Q4 EPS by 1c; Guides FY12 EPS

Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q4 EPS of $1.77, $0.01 better than the analyst estimate of $1.76. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.54 billion.

Watson Pharmaceuticals, Inc. sees FY2012 EPS of $5.50-$5.80, versus the consensus of $5.60.

For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Optimum Communications gets NYSE non-compliance notice over stock price